Кандидемия и острый диссеминированный кандидоз у больных в отделениях интенсивной терапии
Диссертация
Диагностика кандидемии и острого диссеминированного кандидоза должна включать раннее выявление больных с факторами риска, многократные посевы крови и материала из очагов поражения на специальные питательные среды, идентификацию вида возбудителя и определение его чувствительности к антимикотическим препаратам in vitro. Наиболее частыми клиническими проявлениями кандидемии и острого… Читать ещё >
Содержание
- Список сокращений, принятых в диссертации
- Глава 1. Кандидемия и острый диссеминированный кандидоз (обзор литературы)
- 1. 1. Частота кандидемии и ОДК
- 1. 2. Этиология кандидемии и ОДК
- 1. 3. Основные источники возбудителей кандидемии и ОДК
- 1. 4. Факторы риска развития кандидемии и ОДК
- 1. 5. Клинические проявления кандидемии и ОДК
- 1. 6. Летальность у больных с кандидемией и ОДК
- 1. 7. Лечение кандидемии и ОДК
- Глава 2. Материалы и методы исследования
- 2. 1. Общая характеристика исследования
- 2. 2. Характеристика обследованных больных
- 2. 3. Методы обследования больных
- 2. 4. Статистическая обработка результатов
- Глава 3. Результаты собственных исследований
- 3. 1. Характеристика больных с кандидемией и ОДК
- 3. 2. Частота кандидемии и ОДК у больных в отделениях интенсивной терапии
- 3. 3. Спектр возбудителей кандидемии и ОДК у больных в отделениях интенсивной терапии
- 3. 4. Чувствительность возбудителей кандидемии и ОДК к антимикотическим препаратам (МСС1Б М44-Р)
- 3. 5. Факторы риска у больных с кандидемией и ОДК
- 3. 6. Клинические проявления кандидемии и ОДК
- 3. 7. Лечение больных с кандидемией и ОДК
- 3. 8. Летальность у больных с кандидемией и ОДК
- 3. 9. Алгоритм ранней диагностики кандидемии и ОДК
- 3. 10. Клинические случаи острого диссеминированного кандидоза у разных категорий больных
- Глава 4. Обсуждение результатов собственных исследований
- Выводы
Список литературы
- Аравийский Р.А., Горшкова Г. И. / Практикум по медицинской микологии. // Санкт-Петербург. -1995. 40с.
- Баранцевич Е.П. / Поражение внутренних органов грибами Candida и Aspergillus у больных гемобластозами. // Автореферат диссертации. доктора медицинских наук. Санкт-Петербург. -2000. — 40с.
- Баранцевич Е.П., Подольцева Э. И., Кибалкина С. А. и др. / Диссеминированный микоз, обусловленный Candida krusei, у больной острым миелобластным лейкозом: успешная терапия итраконазолом. // Проблемы медицинской микологии. 2001. — ТЗ, № 1. — С.31−2.
- Белогурова М.Б. (под редакцией). / Детская онкология: Руководство для врачей. // Санкт-Петербург. «СпецЛит». — 2002. — 351с.
- Белянин В.Л. / Исследование патогенетических особенностей инфекций, вызываемых условно-патогенными грибами. В кн. «Актуальные вопросы общей и военной патологической анатомии». //Санкт-Петербург. — 1999. — С. 14−17.
- Богомолова Т.С., Ильина В. Я. / Эпидемиологические аспекты кандидемии в отделениях интенсивной терапии. // Проблемы медицинской микологии. 2003. — Т5, № 2. — С.24.
- Гельфанд Б.Р., Гологорский В. А., Гельфанд Е. Б. / Кандидозная инфекция в хирургии и интенсивной терапии. // Инфекции и антимикробная терапия. 2000. — Т1. — С.24−36.
- Блинов Н.П. / Биология дрожжевых грибов рода Candida. II Автореферат диссертации. доктора биологических наук. -МЗСССР. ЛенГИДУВ. Ленинград. — 1963. — 34с.
- Блинов H.П. / Candida species и кандидемии: состояние проблемы (обзор). // Проблемы медицинской микологии. 2001. — ТЗ, № 1. -С.4−15.
- Климко H.H., Васильева Н. В., Блинов Н. П., и др. / Перечень основных методов и критериев диагностики микозов. // СПб МАПО. Санкт-Петербург. — 2001. — 24с.
- Рафальский В.В. / Клиническое значение и терапия кандидурии. // Клиническая микробиология и антимикробная химиотерапия. 2001. — Т1, № 3. — С.22−27.
- Реброва О.Ю. / Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. // Москва. -«МедиаСфера». -2002. -312с.
- Реброва Р.Н. / Грибы рода Candida при заболеваниях негрибковой этиологии. Москва. — «Медицина». — 1989. -128с.
- Розенштраух Л.С., Рыбакова Н. И., Виннер М. Г. / Рентгенодиагностика заболеваний органов дыхания. II Москва. -«Медицина». -1987. 639с.
- Саттон Д., Роммерчил А., Ринальди М. / Определитель патогенных и условно-патогенных грибов. // Москва. «Мир». -2001. -468с.
- Сергеев А.Ю., Сергеев Ю. В. / Кандидоз. // Москва. «Триада-X». — 2000. — 472с.
- Сидоренко C.B., Яковлев C.B. / Инфекции в интенсивной терапии. Москва. — «Зеркало М». — 2000. — 144с.
- Страчунский Л.С., Белоусов Ю. Б., Козлов С. Н. (под редакцией Страчунского Л.С.). / Практическое руководство по антиинфекционной химиотерапии. II Москва. «Боргес». — 2002. -384с.
- Флетчер Р., Флетчер С., Вагнер Э. / Клиническая эпидемиология. Основы доказательной медицины. / Москва. -«МедиаСфера». 1998. — 352с.
- Хмельницкий O.K., Быков В. Л., Хмельницкая Н. М. / Патоморфологическая диагностика микозов, вызываемых условно-патогенными грибами: пособие для врачей. // Санкт-Петербург. -СПб МАПО. 2000. — 36с.
- Шиффман Ф.Дж. / Патофизиология крови. II Москва-СПб. -«Бином"-"Невский диалект». 2000. — 448с.
- Abi-Said D., Anaissie Е., Uzun О., et al. / The epidemiology of hematogenous candidiasis caused by different Candida species. // Clin Infect Dis. 1997. — Vol.24. — P.1222−1228.
- Ainbinder D.J., Parmley V.C., Mader Т.Н., and Nelson M.L. / Infectious crystalline keratopathy caused by Candida guilliermondii. II Am J Ophthalmol. 1998. — Vol.125, № 5. — P.723−725.
- Alonso-Valle H., Acha O., Garcia-Palomo J.D., et al. / Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. // Eur J Clin Microbiol Infect Dis. 2003. — Vol.22. — P.254−257.
- Anaissie E.J., RexJ.H., Uzun O., Vartivarian S. I Predictors of adverse outcome in cancer patients with candidemia. // Am J Med. -1998. Vol.104. — P.238−245.
- Andreoni S., Farina C., Lombardi G. / Medical mycology atlas II Systems. 2004. — 239p.
- Annable W.L., Kachmer M.L., DiMarco M., DeSantis D. / Long-term follow-up of Candida endophthalmitis in the premature infant. // J Pediatr Ophthalmol Strabismus. 1990. — Vol.27, № 2. — P. 103−106.
- Armstrong D. / Overview of invasive fungal infections and clinical presentation. // Bailliere’s Clin Infect Dis. 1995. Vol.2: — P. 17−24.
- Ascioglu S., Rex J.H., de Pauw B., et al. / Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. // Clin Infect Dis. -2002. Vol.34. — P.7−14.
- Bahloul A., Jemel S., Koubaa A., Letaief Y., Mhiri M.N. / Emphysematous pyelonephritis. Apropos of 4 cases. // Prog Urol. -1993. Vol.3, № 5. — P.803−811.
- Banerjee S.N., Emori T.G., Culver D.H. et al. / Secular trends in nosocomial primary bloodstream infections in the United States, 19 801 989. National Nosocomial Infections Surveillance System. // Am J Med. 1991. Vol.91. — P.86S-89S.
- Beck-Sague C.M., Jarvis W.R. / Epidemic bloodstream infections associated with pressure transducers: a persistent problem. // Infect Control Hosp Epidemiol. 1989. — Vol.10, № 2. — P.54−59.
- Beck-Sague C.M., Jarvis W.R., the National Nosocomial Infections Surveillance System. / Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980−1989. // J Infect Dis. 1993. — Vol.167. — P. 1247−1251.
- Bennett J.M., Catovsky D., Daniel M. et al. / Proposals for the classification of the acute leukemias. // Br J Haematol 1976. Vol.33. -P.329−331.
- Bernhardt H., Zimmermann K., Sissolak D., et al. / Epidemiological survey on candidemia in Europe: Results of Germany and Austria. Abstract P5−043. // Rev Iberoam Micol. 2000. — Vol.17. -S146.
- Bjerknes R., Vindenes H. / Neutrophilic dysfunction after thermal injury: alteration of phagolysosomal acidification in patients with large burns. // Burns. 1989. Vol.15. — P.77−81.
- Blinkhorn R.J., Adelstein D., Spagnuolo P.J. / Emergence of a new opportunistic pathogen, Candida lusitaniae. II J Clin Microbiol. -1989. Vol.27. -:P.236−240.
- Blot S.I., Vandewoude K.H. / Estimating attributable mortality of candidemia: clinical judgement vs. matched cohort studies. // Eur J Clin Microbiol Infect Dis. 2003. — Vol.22. — P. 132−133.
- Blot S.I., Vandewoude K.H., Hoste E.A., Colardyn F.A. / Effects of nosocomial candidemia on outcomes of critically ill patients. // Am J Med. 2002. — Vol.113, № 6. — P.480−485.
- Blumberg H.M., Jarvis W.R., Soucie J.M., et al. / Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. // Clin Infect Dis. 2001. -Vol.33. P. 177−186.
- Bodey G., Bueltmann B., Duguid W., et al. / Fungal infections in cancer patients: an international autopsy survey. // Eur J Clin Microbiol Infect Dis. 1992. — Vol.11. — P.99−109.
- Bodey G.P., Mardani M., Hanna H.A., et al. / The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. // Am J Med. 2002. -Vol.112, № 5. — P.380−385.
- Bonatti H, Steurer W, Konigsrainer A, et al. Infection of the pancreatic duct following pancreas transplantation with bladder drainage. J Chemother 1995- 7: 442−5.
- Borzotta A.P., Beardsley K. / Candida infections in critically ill trauma patients: a retrospective case-control study. // Arch Surg. -1999. Vol.134. — P.657−664.
- Burchard K.W. / Fungal sepsis. // Infect Dis Clin North Am. // 1992.-Vol.6.-P.677−692.
- Calderone R.A. / Host parasite relationships in candidiasis. // Mycoses. 1989. — Vol.32 (suppl 2). — P. 12−17.
- Calderone R.A., Fonzi W.A. / Virulence factors of Candida albicans. II Trends in Microbiology. 2001. — Vol.9. — P.327−335.
- Canver C.C., Patel A.K., Kosolcharoen P. et Voytovich M.C. I Fungal purulent constrictive pericarditis in a heart transplant patient. // Ann Thorac Surg. 1998. — Vol.65, № 6. — P. 1792−1794.
- Carrega G., Riccio G., Santoriello L., et al. / Candida famata fungemia in a surgical patient successfully treated with fluconazole. II Eur J Clin Microbiol Infect Dis. 1997. — Vol.16, № 9. — P.698−699.
- Castaldo P., Stratta R.J., Wood R.P., et al. / Clinical spectrum of fungal infections after orthotopic liver transplantation. // Arch Surg. -1991. Vol.126.-P.149−156.
- Chiew Y.F. / Candidal renal papillary necrosis: report of a case and review. //Singapore Med J. 1996. — Vol.37, № 1. — P. 119−121.
- Cole G.T., Halawa A.A., Anaissie E.J. / The role of the gastrointestinal tract in hematogeneous candidiasis: from the laboratory to the bedside. // Clin Infect Dis. 1996. — Vol.22 (Suppl 2). — S73-S88.
- Coleman D.C., Rinaldi M.G., Haynes K.A., et al. / Importance of Candida species other than Candida albicans as opportunistic, pathogens. II Med Mycol. 1998. — Vol.36. — P. 156−165.
- Cunha B.A. / Intravenous line infections. // Critical Care Clinics. -1998.-Vol.14.-P.339−346.
- D’Amelio L.F., Wagner B., Azimuddin S., et al. / Antibiotic patterns associated with fungal colonization in critically ill surgical patients. // Am Surg. 1995. — Vol.61. — P. 1049−1053.
- Dean D.A., Burchard K.W. / Fungal infection in surgical patients. // Am J Surg. 1996. — Vol.171. — P.374−382.
- Deitch E.A. / The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. // Arch Surg. 1990. — Vol.125. — P.403−404.
- Denning D.W. / Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. // J Antimicrob Chemother. 1991. Vol.28. — P.1−16.
- Diaz E., et al. / Nosocomial candidemia risk factors. // Intensive Care Med. 1998. — Vol.24 (Suppl 1). — S143.
- Diekema D.J., Messer S.A., Hollis R.J., et al. / An outbreak of Candida parapsilosis prosthetic valve endocarditis. // Diagn Microbiol Infect Dis. 1997. — Vol.29, № 3. — P.147−153.
- Djulbegovic B., Sullivan D.M. / Decision making in oncology evidence-based management. // United States of America. Churchill Livingstone Inc. — 1997. — 532p.
- Dube M.P., Heseltine P.N.R., Rinaldi M.G., et al. / Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. // Clin Infect Dis. 1994. — Vol.18. — P.77−82.
- Eggimann P., Garbino J., et Pittet D. / Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. // Lancet Infect Dis. 2003. — Vol.3. — P.685−702.
- Filler S.G., Ibe B.O., Ibrahim A.S., et al. / Mechanisms by which Candida albicans induces endothelial cell prostaglandin synthesis. // Infect Immun. 1994. — Vol.62. — P.1064−1069.
- Filler S.G., Pfunder A.S., Spellberg B.J. / Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. // Infect Immun. 1996. — Vol.64. -P. 2609−2617.
- Filler S.G., Swerdloff J.N., Hobbs C., et al. / Penetration and damage of endothelial cells by Candida albicans. / Infect Immun. -1995. Vol.63. P.976−983.
- Finkelstein R., Reinhertz G., Hashman N. et Merzbach D. / Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit. // Infect Control Hosp Epidemiol. 1993. — Vol.14. P.10 58 710 590.
- Fornadley J.A., Parker G.S., Rickman L.S. et Paparello S. / Candida myositis manifesting as a discrete neck mass. // Otolaryngol Head Neck Surg. 1990. Vol.102, № 1. — P.74−76.
- Fowler S.L., Rhoton B., Springer S.C., et al. / Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive-care unit. // Infect Control Hosp Epidemiol. 1998. — Vol.19, № 5. — P.343−345.
- Fraser V.J., Jones M., Dunkel J. et al. / Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. // Clin Infect Dis. 1992. — Vol.15. — P.414−421.
- Fratti R.A., Ghannoum M.A., Edwards J.E., et al. / Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. // Infect Immun. 1996. -Vol.64. -P.4714−4718.
- Fridkin S.K., Jarvis W.R. / Epidemiology of nosocomial fungal infections. // Clin Microbiol Rev. 1996. — Vol.9. — P.499−511.
- Gadd M.A., Hansbrough J.F., Hoyt D.B. / Defective T-cell surface antigen expression after mitogen stimulation. An index of lymphocyte dysfunction after controlled murine injury. / Ann Surg. 1989. — Vol.209. — P.112−118.
- Garbino J., Kolarova L., Rohner P., et al. / Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. // Medicine (Baltimore). 2002. — Vol.81, № 6. — P.425−433.
- Ghannoum M.A., Abu-Elteen K.H. / Pathogenicity determinants of Candida. II Mycoses. 1990. — Vol.33. — P.265−282.
- Giamarellou H., Antoniadou A. / Epidemiology, diagnosis, and therapy of fungal infections in surgery. // Infect Control Hosp Epidemiol.- 1996. Vol.17. -P.558−564.
- Gloeckner A., Abel P., Bernhardt H., Zimmermann K. / Mycological findings upon admission to a non-surgical ICU. // 42nd ICAAC. Abstracts M-874. San Diego, California, September 27−30, 2002. — P.389.
- Goodman J.L., Winston D.J., Greenfield R.A., et al. / A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. // N Engl J Med. 1992. — Vol.326, № 13.- P.845−851.
- Gottfredsson M. et Perfect J.R. / Fungal meningitis. // Seminars in neurology. 2000. — Vol.20, № 3. — P.307−321.
- Grillot R., Faure O., Fruit J., et al. / Working group: ECMM prospective epidemiological survey of candidemia in Europe: Report from France (682 cases). // Abstract P5−036. Rev Iberoam Micol. -2000. — Vol.17. -S144.
- Guinet R., Chanas J., Goullier A., et al. / Fatal septicemia due to amphotericin B resistant Candida lusitaniae. II J Clin Microbiol. -1983.-Vol.18.-P.443−444.
- Gumbo T., Chemaly R.F., Isada C.M., et al. / Late complications of Candida (Torulopsis) glabrata fungemia: description of a phenomenon. // Scand J Infect Dis. 2002. — Vol.34. — P:817−818.
- Hadley S., Lee W.W., Ruthazer R., Nasraway Jr.S.A. / Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients. // Crit Care Med. 2002. — Vol.30, № 8.-P. 1808−1814.
- Heron B., Texier J.L., Boespflug O., et al. / Acute hydrocephalus due to Candida meningitis in a 2-month-old infant. // Arch Fr Pediatr. -1990. Vol.47, № 4. — P.279−281.
- Hickey W.F., Sommerville L.H., Schoen F.J. / Disseminated Candida glabrata: report of a uniquely severe infection and a literature review. // A J Clin Pathol. 1983. Vol.80. — P.724−727.
- Hildebrand T.S., Nibbe L., Frei U., Schindler R. / Bilateral emphysematous pyelonephritis caused by Candida infection. // Am J Kidney Dis. -1999. Vol.33, № 2. — E10.
- Holzheimer R.G. et Dralle H. / Management of mycoses in surgical patients (Review). // Eur J Med Res. 2002. — Vol.7. — P.200−226.
- Huang Y.C., Lin T.Y., Leu H.S., et al. / Yeast carriage on hands of hospital personnel working in intensive care units. // J Hosp Infect. -1998. Vol.39, № 1. — P.47−51.
- Hung C.C., Chen Y.C., Chang S.C., et al. / Nosocomial candidemia in a university hospital in Taiwan. // J Formos Med Assoc. -1996. Vol.95, № 1. — P. 19−28.
- Hurley R. / Acute disseminated (septicaemic) moniliasis in adults and children. // Postgraduate Medical Journal. 1964. — Vol.40. -P.644−653.
- Irby P.B., Stoller M.L. et McAninch J.W. / Fungal bezoars of the upper urinary tract. //J Urol. 1990. — Vol.143. — P.447−451.
- Jarvis W.R. / Epidemiology of nosocomial fungal infections, with emphasis on Candida species. // Clin Infect Dis. 1995. Vol.20. -P. 1526−1530.
- Jarvis W.R. / The epidemiology of colonization. // Infect Control Hosp Epidemiol. 1996. — Vol.17. — P.47−52.
- Jarvis W.R., Martone W.J. / Predominant pathogens in hospital infections. //J Antimicrob Chemother. 1992. Vol.29. — P. 19−24.
- Jeejeebhoy K.N. / Total parenteral nutrition: potion or poison? // Am J Clin Nutr 2001. Vol.74. — P. 160−163.
- Johnson M.D., Gottfredsson M., Perfect J.R., et al. / Polyfungemia at a tertiary care medical center 1992−2001: a decade of experience. // 42nd ICAAC. Abstracts M-881. — San Diego, California, September 2730, 2002. -P.391.
- Kaben U., Blaschke-Hellmessen R., Hellwig S. / Persistence and variability of yeasts isolated from hospitalized patients: a comparison of results from Rostock and Dresden. // Mycoses. 1997. — Vol.40 (Suppl 1).-P.76−80.
- Karlowsky J.A., Zhanel G.G., Klym K.A., et al. / Candidemia in a Canadian tertiary care hospital from 1976 to 1996. // Diagn Microbiol Infect Dis. 1997. — Vol.28. — P.5−9.
- Karyotakis N.C., Anaissie E.J., Hachem R., et al. / Comparison of efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice. // J Infect Dis. 1993. — Vol.168. -P.1311−1313.
- Kauffman C.A., Vazquez J.A., Sobel J.D., et al. / Prospective multicenter surveillance study of funguria in hospitalized patients. // Clin Infect Dis. 2000. — Vol.30. — P.14−18.
- Kawakami S., Ono Y., Miyazawa Y. et Yamaguchi H. / Survey of fungemia cases during the past seventeen years at Teikyo University Hospital. // Kansenshogaku Zasshi. 1998. — Vol.72, № 2. — P. 105−113.
- Kennedy M.J., Volz P.A. / Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. II Sabouradia. 1985. — Vol.23. — P.265−273.
- Kibbler C.C., Mackenzie D.W.R. et Odds F.C. / Principles and practice of clinical mycology. // England. John Wiley & Sons. — 1996. -268p.
- Klingspor L., Tornquist E., Johansson A., et al. / ECMM’s survey of candidemia in Europe: Report from Sweden. // Abstract P5−044. -Rev Iberoam Micol. 2000. — Vol.17. — S147.
- Kontoyiannis D.P., Lewis R.E. / Antifungal drug resistance of pathogenic fungi. / Lancet 2002. Vol.359(9312). — P. 1135−1144.
- Kossoff E.H., Buescher E.S., Karlowicz M.G. / Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. // Pediatr Infect Dis J. 1998. — Vol.17. — P.504−508.
- Krause W., Matheis H., Wulf K. / Fungemia and funguria after oral administration of Candida albicans. // Lancet. 1969. — Vol.1. — P.598−599.
- Kuijpers A.F., Tan C.S. / Fungi and yeasts isolated in mycological studies in skin and nail infections in The Netherlands, 1992−1993. // Ned Tijdschr Geneeskd. 1996. — Vol.140, № 19. — P. 1022−1025.
- Kurtzman C.P., Fell J.W. (Ed by). / Yeasts. A taxonomic study. 4th ed. Elsevier. — 1999. — 1055p.
- Kwon-Chung K.J., Bennett J.E. / Medical mycology. // Lea&Febidger. Philadelphia-London. — 1992. — 886p.
- Leleu G., Aegerter P., Guidet B.- College des Utilisateurs de Base de Donnees en Reanimation. / Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. // J Crit Care. 2002. -Vol.17, № 3. — P. 168−175.
- Levenson D., Pfaller M.A., Smith M.A., et al. / Candida zeylanoides: another opportunistic yeast. // J Clin Microbiol. 1991. -Vol.29, № 8. — P. 1689−1692.
- Levy M.M., Fink M.P., Marshall J.C., et al. / 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. // Crit Care Med. 2003. — Vol.31, № 4. — P. 1250−1256.
- Lisch S., Steudel W.I. / Unusual course of candidiasis of the central nervous system. // Dtsch Med Wochenschr. 1994. — Vol.119, № 1−2.-P.13−18.
- Lundstrom T., Sobel J. / Nosocomial candiduria: a review. // Clin Infect Dis. 2001. — Vol.32. — P.1602−1607.
- Maid D.G., Stolz S.M., Wheeler S., et al. / Prevention of central venous catheter-related bloodstream infection by use of an antisepticimpregnated catheter. // Ann Intern Med. 1997. — Vol.127. -P.257−266.
- Maki D.G., Stolz S.M., Wheeler S. et Mermel LA. / Prevention of central venous catheter-related blood-stream infection by use of anantiseptic-impegnated catheter. //Ann Intern Med. 1997. — Vol.127. -P.257−266.
- Marchetti O., Bille J., Fluckiger U., et al. / Epidemiology of candidemia in Swiss tertiary care hospitals: secular trend, 1991−2000. // Clin Infect Dis. 2004. — Vol.38. — P.311 -320.
- Marshall J.C., Christou K.V., Meakins J.L. / The gastrointestinal tract. The «undrained abscess» of multiple organ failure. // Ann Surg. -1993. -Vol.218. P. 111−119.
- Martin G.S., Mannino D.M., Eaton S. et Moss M. / The epidemiology of sepsis in the United States from 1979 through 2000. // N Engl J Med. 2003. — Vol.348. — P. 1546−1554.
- Martino P., Girmenia C., Micozzi A., et al. / Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. // Eur J Clin Microbiol Infect Dis. 1994. — Vol.13. — P.797−804.
- Martino P., Girmenia C., Venditti M., et al. / Candida colonization and systemic infection in neutropenic patients. A retrospective study. // Cancer. 1989. — Vol.64. — P.2030−2034.
- Meis J., Petrou M., Bille J., et al. / A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. // Diagn Microbiol and Infect Dis. 2000. — Vol.36. P.215−223.
- Menezes A.V., Sigesmund D.A., Demajo W.A. et Devenyi R.G. / Mortality of hospitalized patients with Candida endophthalmitis. // Arch Intern Med. 1994. — Vol.154, № 18. P.2093−2097.
- Mermel L.A., Farr B.M., Robert J. et al. / Guidelines for the Management of Intravascular Catheter-Related Infections. // Clin Infect Dis. 2001. — Vol.32. — P.1249−1272.
- Merz W.G., Karp J.E., Schron D. et Saral R. / Increased incidence of fungemia caused by Candida krusei. II J Clin Microbiol. 1986. -Vol.24, № 4. — P.581−584.
- Meunier F., Aoun M., Bitar N. / Candidemia in immunocompromised patients. // Clin Infect Dis. 1992. — Vol.14. -S120−125.
- Morace G., Sanguinetti M., Posteraro B., et al. / Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis. // J Clin Microbiol. 1997. — Vol.35, № 3. — P.667−672.
- Morris B.S., Chudgar P.D., Manejwala O. / Primary renal candidiasis: fungal mycetomas in the kidney. II Australas Radiol. -2002. Vol.46, № 1. — P.57−59.
- Mullen C.A., El-Baki H.Abd., Samir H., et al. / Non-a/?>/'ca/?s Candida is the most common cause of candidemia in pediatric cancer patients. // Support Care Cancer. 2003. — Vol.11. — P.321−325.
- National Committee for Clinical Laboratory Standards. / Reference method for broth dilution antifungal susceptibility testing of yeasts- approved standard M27-A. // Villanova. PA: NCCLS. — 1997.
- National Nosocomial Infections Surveillance. / NNIS system report, data summary from January 1992-April 2000. Issued June 2000. // Am J Infect Control. 2000. — Vol.28. — P.429−448.
- Nguyen M.H., Peacock J.E., Tanner D.C., et al. / Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective, observational study. // Arch Intern Med. 1995. — Vol.155. — P.2429−2435.
- Nguyen M.H., Peacock Jr.J.E., Morris A.J., et al. / The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. // Am J Med. 1996. — Vol.100. — P.617−623.
- O’Grady N.P., Alexander M., Dellinger E.P., et al. / Guidelines for the prevention of intravascular catheter-related infections. // Clin Infect Dis. 2002. — Vol.35. — P.1281−1307.
- Odds F.C. / Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects. // Int J Antimicrob Agents. -1996.-Vol.6.-P.141−144.
- Odds F.C. / Etiology and epidemiology of Candida species. // Zbl. Bakt. Hyg. 1984. — A 257. — P.207−212.
- Pappas P.G., Rex J.H., Lee J., et al. / A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. // Clin Infect Dis. 2003. -Vol.37. — P.000−000.
- Pappas P.G., Rex J.H., Sobel J.D., et al. / Guidelines for treatment of candidiasis. // Clin Infect Dis. 2004. — Vol.38. — P.161−189.
- Parker J.C., McCloskey J.J., Solanki K.V., et al. / Candidosis: the most common postmortem cerebral mycosis in an endemic fungal area. // Surg Neurol. 1976. — Vol.6. — P. 123−128.
- Patel B., Khosla A., Chenoweth J.L. / Bilateral fungal bezoars in the renal pelvis. // Br J Urol. 1996. — Vol.78, № 4. — P.651−652.
- Petri M.G., Konig J., Moecke H.P., et al. / Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. // Intensive Care Med. 1997. — Vol.23. -P.317−325.
- Pittet D. / Links between fungal colonisation and infection. In: Vincent JL (ed.). The management of fungal infection in the ICU. // Liposome Co. 1999. — P.33−42.
- Pittet D. / Nosocomial bloodstream infections. In: Wenzel R.P. (ed.). Prevention and control of nosocomial infections. // 2d Edn. -Williams and Wilkins. Baltimore. — 1993. — P.512−555.
- Pittet D., Monod M., Suter P.M., et al. / Candida colonization and subsequent infections in critically ill surgical patients. // Ann Surg. -1994. Vol.220. — P.751−758.
- Raad I. / Intravascular-catheter-related infections. // Lancet. -1998. Vol.351. — P.893−898.
- Rabinovici R., Szewczyk D., Ovadia P., et al. / Candida pericarditis: clinical profile and treatment. // Ann Thorac Surg. 1997. -Vol.63.-P. 1200−1204.
- Rantala A., Niinikoski J., Lehtonen O.P. / Early Candida isolations in febrile patients after abdominal surgery. // Scand J Infect Dis. 1993. — Vol.25. — P.479−485.
- Redkar R.J., Dube M.P., McCleskey F.K., et al. / DNA fingerprinting of Candida rugosa via repetitive sequence-based PCR. // J Clin Microbiol. 1996. — Vol.34, № 7. — P. 1677−1681.
- Rennert G., Rennert H.S., Pitlik S., et al. / Epidemiology of candidemia a nationwide survey in Israel. // Infection. — 2000. — Vol.28, № 1. — P.26−29.
- Rentz A., Halpern M.T., Bowden R. / The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. // Clin Infect Dis. 1998. — Vol.27. — P.781−788.
- Rex J.H., Bennett J.E., Sugar A.M., et al. / A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. // N Engl J Med. 1994. -Vol.331. — P. 1325−1330.
- Rex J.H., Bennett J.E., Sugar A.M., et al. / Intravascular catheter exchanges and the duration of candidemia. // Clin Infect Dis. 1995. -Vol.21. -P.994−996.
- Rex J.H., Walsh T.J., Sobel J.D., et al. / Practice guidelines for the treatment of candidiasis. // Clin Infect Dis. 2000. — Vol.30. — P.662−678.
- Richards M.J., Edwards J.R., Culver D.H. et Gaynes R.P. / Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. // Crit Care Med. 1999. — Vol.27, № 5. — P.887−892.
- Richardson M.D., Kokki M. / Therapeutic guidelines in systemic fungal infections. II London. Current Medical Literature Ltd. — 1998. -62p.
- Richet H., Roux P., Des Champs C., et al. / Candidemia in French hospitals: incidence rates and characteristics. // Clin Microbiol Infect. -2002. Vol.8. -P.405−412.
- Richet H.M., Andremont A., Tancrede C., et al. / Risk factors for candidemia in patients with acute lymphocytic leukemia. // Rev Infect Dis. 1991. — Vol.13. — P.211−215.
- Rodriguez-Adrian L.J., King R.T., Tamayo-Derat L.G., et al. / Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. // Medicine (Baltimore).-2003. Vol.82, № 3. — P. 187−202.
- Ronveaux O., Jans B., Suetens C., Carsauw H. / Epidemiology of nosocomial bloodstream infections in Belgium, 1992−1996. // Eur J Clin Microbiol Infect Dis. 1998. — Vol.17, № 10. — P.695−700.
- Samonis G., Gikas A., Toloudis P., et al. / Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. // Eur J Clin Microbiol Infect Dis. 1994. — Vol.13. P.665−667.
- Samonis G., Thomakos N., Liakakos T., et al. / Effects of cefepime and meropenem on the gastrointestinal colonization of surgical patients by Candida albicans. II Chemotherapy. 2001. -Vol.47. — P.350−353.
- San Miguel L.G., Cobo J., Martos I., et al. / Candidemia in children with congenital cardiopathy. // 42nd ICAAC. Abstracts M-872. — San Diego, California, September 27−30, 2002. — P.389.
- Sanchez V., Vazquez J.A., Barth-Jones D., et al. / Epidemiology of nosocomial acquisition of Candida lusitaniae. II J Clin Microbiol. -1992.-Vol.30, № 11. P.3005−3008.
- Sandven P. / Epidemiology of candidemia. // Rev Iberoam Micol. -2000. -Vol.17. -P.73−81.
- Saral R. / Candida and Aspergillus infection in immunocompromised host: an overview. // Rev Infect Dis. 1991. -Vol.13. -P.487−492.
- Schrader W. / Endogenous Candida endophthalmitis. Early diagnosis and early vitrectomy improve the prognosis. // Fortschr Ophthalmol. 1990. — Vol.87, № 4. — P.331−335.
- Sherertz R.J., Gledhill K.S., Hampton K.D., et al. / Outbreak of Candida bloodstream infections associated with retrograde medication administration in a neonatal intensive care unit. // J Pediatr. 1992. -Vol.120, № 3. — P.455−461.
- Singh N. / Changing spectrum of invasive candidiasis and its therapeutic implications. // Clin Microbiol Infect. 2001. Vol.7(Supplement 2). — P. 1−7.
- Slavin M.A. et the Australian mycology interest group. The epidemiology of candidemia and mould infections in Australia. / JAC. -2002. Vol.49(Suppl 1). — P.3−6.
- Slotman G.J., Shapiro E., Moffa S.M. / Fungal sepsis: multisite colonization versus fungemia. // Am Surg. 1994. — Vol.60. — P. 107 113.
- Sobel J.D. / Fungal infections of the genitourinary tract. In: Clinical Mycology. Eds. E. Anaissie, M. Meginnis, M.Pfaller. // Churchill Livingstone. 2003. — P.496−509.
- Sobel J.D., Vazquez J.A. / Fungal infections of the urinary tract. // World J Urol. 1999. — Vol.17. — P.410−414.
- Stevens D.A., Bennet J.E. / Antifungal agents. In: Mandell, Douglas, and Bennett’s Principles and practice of infectious diseases. // Fifth edn. Churchill Livingstone. — 2000.
- Strausbaugh L.J., Sewell D.L., Ward T.T., et al. / High frequency of yeast carriage on hands of hospital personnel. // J Clin Microbiol. -1994. Vol.32, № 9. — P.2299−2300.
- Sugar A.M. et Stevens D.A. / Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature. / Cancer. 1985. — Vol.56, № 2. — P.318−320.
- Taylor G.D., Buchanan-Chell M., Kirkland T., et al. / Trends and sources of nosocomial fungaemia. // Mycoses. 1994. — Vol.37, № 5−6.- P.187−190.
- Tortorano A.M., Biraghi E., Astolfi A., et al. / European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. // J Hosp Infect. 2002. -Vol.51. -P.297−304.
- Tortorano A.M., Viviani M.A., Rigoni A.L., et al. / ECMM survey of candidemia in Europe: Report from Italy. // Abstract P5−035. Rev Iberoam Micol. — 2000. — Vol.17. — S143.
- Trick W.E., Fridkin S.K., Edwards J.R. / Secular trend of hospital-asquired candidemia among intensive care units patients in the United States during 1989−1999. // Clin Infect Dis. 2002. — Vol.35. — P.627−630.
- Vazquez J.A., Sanchez V., Dmochowski C., et al. / Nosocomial acquisition of Candida albicans: an epidemiologic study. // J Infect Dis.- 1993. Vol.168. — P. 195−201.
- Vincent J.L. / The management of fungal infection in the ICU. // Liposome Co. 1999. — 114p.
- Vincent J.L., Anaissie E., Bruining H., et al. / Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. // J Intensive Care Med. 1998. — Vol.24, № 3. — P.206−216.
- Vincent J.L., Bihari G.J., Suter P.M., et al. / The prevalence of nosocomial infection in intensive care units in Europe (EPIC). // JAMA. 1995. — Vol.274. — P.639−644.
- Voice R.A., Bradley S.F., Sangeorzan J.A., et al. / Chronic candidal meningitis: an uncommon manifestation of candidiasis. // Clin Infect Dis. 1994. — Vol.19: 60.
- Von Eiff M., Zohlsdorf M., Roos N. et al. / Pulmonary fungal infections in patients with hematological malignancies diagnostic approaches. //Ann Hematol. — 1995. — Vol.70, № 3. — P.135−141.
- Voss A., Hollis R.J., Pfaller M.A., Wenzel R.P., Doebbeling B.N. / Investigation of the sequence of colonization and candidemia in nonneutropenic patients. // J Clin Microbiol. 1994. — Vol.32. P.975−980.
- Voss A., Kluytmans J.A., Koeleman J.G., et al. / Occurrence ofyeast blood stream infections between 1987 and 1995 in five Dutchuniversity hospitals. // Eur Clin Microbiol Infect Dis. 1996. — Vol.15, № 12.- P.909−912.
- Walsh T.J., Hutchins G.M., Bulkley B.H. et Mendelsohn G. / Fungal infections of the heart: analysis of 51 autopsy cases. // Am J Cardiol. 1980. — Vol.45, № 2. — P.357−366.
- Wenzel R.P. / Nosocomial candidemia: risk factors and attributable mortality. // Clin Infect Dis. 1995. — Vol.20. P.1531−1534.
- Wenzel R.P., Pfaller M.A. / Candida species: emerging hospital bloodstream pathogens. // Infect Control Hosp Epidemiol. 1991. -Vol.12.-P.523−524.
- Wey S.B. / Fungi. In: Wenzel R. et al. A guide to infection control in the hospital. // Decker BC Ink. 1998. — P. 154−158.
- Wey S.B., Motomi M., Pfaller M.A., et al. / Hospital-acquired candidemia: the attributable mortality and excess length of stay. // Arch Intern Med. 1988. — Vol.148. — P.2642−2645.
- Whitby S., Madu E.C., Bronze M.S. / Case report: Candida zeylanoides infective endocarditis complicating infection with the human immunodeficiency virus. // Am J Med Sci. 1996. — Vol.12, № 3. -P.138−139.
- White M.H. / The contribution of fluconazole to the changing epidemiology of invasive candidal infections editorial. // Clin Infect Dis.- 1997. Vol.24. — P. 1129−1130.
- Wiley J.M., Smith N., Leventhal B.G., et al. / Invasive fungal disease in pediatric acute leukemia with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. // J Clin Oncol. 1990. — Vol.8. — P.280−286.
- Wingard J.R. / Importance of Candida species other than C.albicans as pathogens in oncology patients review. // Clin Infect Dis.- 1995. Vol.20.-P. 115−125.
- Wingard J.R., Merz W.G., Rinaldi M.G., et al. / Association of Torulopsis glabrata infections with fluconazole prophylaxis inneutropenic bone marrow bcmsplant patients. // Antimicrob Agents Chemother. 1993. — Vol.37, № 9. — P.1847−1849.
- Wingard J.R., Merz W.G., Rinaldi M.G., et al. / Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. // N Engl J Med. 1991. — Vol.325. — P.1274−1277.
- Wisplinghoff H., Bischoff T., Tallent S.M., et al. / Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective Nationwide Surveillance Study. // Clin Infect Dis. 2004. -Vol.39.-P.309−317.
- Yamamura D.L.R., Rotstein C., Nicolle L.E., et al. / Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992−1994. // CMAJ. 1999. — Vol.160. P.49399.